-+ 0.00%
-+ 0.00%
-+ 0.00%

Evotec Deepens CELMoDs Alliance With Bristol Myers Squibb As Molecular Glue Degrader Pipeline Expands

Benzinga·04/24/2025 06:36:37
Listen to the news

Key scientific achievements expand the pipeline of high value molecular glue degraders for unmet medical needs

Performance-based and program-based payments of in total US$ 75 m to Evotec